Anna is a pharmacist with a post graduate master in Hospital pharmacy. After two years in a Hospital she joined the pharmaceutical Industry, where she developed a long experience in the matter of Quality in Drug Development. She started in 1992 at Glaxo Italy where contributed to the implementation of GLP, GCP and GMP for IMP. In 1992 from the Affiliate of a British multinational company she moved to the Headquarters of Zambon, an Italian multinational company as Head of Planning and Control of R&D Projects and QA. Since 1996 she is Responsible for R&D QA. During this period she developed a long experience in GxP with the implementation of a global Quality System and recently, of the Quality for the Pharmacovigilance System. She is deeply involved in audits of clinical studies, pharmacovigilance and IMP as well as CROs and providers of GxP services, like Central laboratories and Commercial archives. As a member of the Validation team she participated in several projects of Computer System Validation auditing on site and in house. She has managed Inspections held by Italian and European Authorities. Participates in several Italian and International meetings and has published on GxP topics. She is Vice president of the Italian Society for Applied Pharmacological Sciences, SSFA and is an active member of the Italian Group of R&D QA, GIQAR.